Pharmaceutical Technology\'s In the Lab eNewsletter-12-05-2018

Pharmaceutical Technology's In the Lab eNewsletter

Microdialysis Technology Updates Data Access for Oncology Drug Development

November 29, 2018

New Technology

13

12

Charles River Laboratories has announced a data expansion in its compendium of tumor models for oncology drug R&D.

High-Throughput Microplate Reader Cuts Down Screening Time

November 29, 2018

New Technology

13

12

A new, high-throughput microplate reader cuts down on screening time and works faster than standard ultra-high-performance liquid chromatography processes.

NIBRT, Valitacell Aim to Validate New Analytical Technology

November 29, 2018

News

13

12

The partnership, co-funded by Enterprise Ireland, will develop technologies for monitoring the quality of biopharma processes.

QPS Expands US-Based Phase I Clinical Trial Capabilities

November 29, 2018

News

13

12

The contract research organization has increased its US-based early phase clinical capacity and doubled its specialty lab space.

IRBM Strengthens Position in Neurodegenerative Disease Research Through Extended Collaboration

November 20, 2018

News

13

12

IRBM has extended its collaboration with CHDI Foundation to progress the development of therapeutics for Huntington's disease.

Ending the Impasse on Drug Pricing

November 09, 2018

News

13

12

More-and earlier-interaction between R&D and payers will be essential if innovative therapies are to become more accessible for patients, and more profitable for manufacturers, said panelists at the 2018 Galien Foundation Forum.

Survey Predicts Drug Product Formulation Recognition and Increasing Budgets

November 08, 2018

News

13

12

Formulation issues cause significant drug project delays and project failures, according to a 2018 survey conducted by Informa Pharma Intelligence, Rentschler Biopharma, and LEUKOCARE.

Opioid Overdose Reversal Products are Chemically Stable Well Past Expiration Date, Says Study

November 06, 2018

News

13

12

Researchers evaluated the chemical stability of two different naloxone products administered to prevent opioid overdose deaths and found the products to have a significantly extended shelf life than previously known.